Collectively, our resultsshowed that doxorubicin significantly reduced ATPase activity,protein expression levels in cancer lines and also showed bindingsite interactions with unique amino acid residues (Thr 198) andcommon amino acid residues (Tyr 200 and Thr 201) in DDX3. The gene discussed is DNAH8; the disease is cancer.